| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/16/2001 | US6303151 Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment |
| 10/16/2001 | US6303150 Method for producing nanocapsules with crosslinked protein-based walls nanocapsules thereby obtained and cosmetic, pharmaceutical and food compositions using same |
| 10/16/2001 | US6303149 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
| 10/16/2001 | US6303148 Process for the preparation of a controlled release system |
| 10/16/2001 | US6303147 For making solid dosage forms such as tablets which are suitable for oral, nasal, rectal and vaginal administration |
| 10/16/2001 | US6303146 Solid oral dosage form comprising a combination of metformin and glibenclamide |
| 10/16/2001 | US6303144 Does not release all drug inregion having a low ph, such as in the stomach, but only in region having a ph relatively near neutral range, such as in small bowel and large bowel, plug gradually gels from upper surface |
| 10/16/2001 | US6303143 Pharmaceutical product |
| 10/16/2001 | US6303142 Administering sustained release analgesic formulation; applying apparatus capable of generating controlled heat by exposing oxygen activated exothermic medium; heating skin portion |
| 10/16/2001 | US6303141 Passive sustained release transdermal drug delivery system |
| 10/16/2001 | US6303140 For therapy of skin disorders |
| 10/16/2001 | US6303137 For applying bioactive substances |
| 10/16/2001 | US6303136 For cell screening and implantation into a mammalian host |
| 10/16/2001 | US6303134 Selecting in situ locus in central nervous system which includes agonist receptors and heterologous receptors that are coupled to common g-proteins; seteotaxially delivering biodegradable, non-spherical polymeric microstructure |
| 10/16/2001 | US6303132 Administering progesterone using EMU oil |
| 10/16/2001 | US6303131 Compositions of insoluble film-forming polymers and uses thereof |
| 10/16/2001 | US6303113 Preservative chlorobutanol, wherein said human protein has erythropoietin-like activity or granulocyte-colony stimulating factor-like activity |
| 10/16/2001 | US6303103 1,1,1,2-tetrafluoroethane as propellant; inhalants. |
| 10/16/2001 | US6302863 Method for removal of lipids via a perfluorocarbon tumescent solution |
| 10/16/2001 | CA2181156C Macroencapsulated secretory cells |
| 10/16/2001 | CA2152615C Atovaquone pharmaceutical compositions |
| 10/16/2001 | CA2137296C Phospholipid derivative and reactive vesicle-forming agent |
| 10/12/2001 | CA2318665A1 Method of treating onychomycosis |
| 10/12/2001 | CA2305062A1 Compositions for and method of treatment for psoriasis |
| 10/11/2001 | WO2001076038A2 Permanent magnet keeper-shield assembly |
| 10/11/2001 | WO2001074917A1 Hydrophilic polymers, pressure sensitive adhesives and coatings |
| 10/11/2001 | WO2001074839A2 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 10/11/2001 | WO2001074448A1 Stable thyroid hormone preparations and method of making same |
| 10/11/2001 | WO2001074445A1 Low frequency generating poultice |
| 10/11/2001 | WO2001074432A1 Microencapsulated fragrances and methods of coating microcapsules |
| 10/11/2001 | WO2001074431A2 Dispensing devices and liquid formulations |
| 10/11/2001 | WO2001074400A1 Transporters and drug delivery system by using the same |
| 10/11/2001 | WO2001074397A1 Powdery preparation for transmucosal administration containing a polymeric form of drug and exhibiting improved storage stability |
| 10/11/2001 | WO2001074396A1 Composition and method for promoting oral health |
| 10/11/2001 | WO2001074395A2 Amiodarone-containing parenteral solution |
| 10/11/2001 | WO2001074392A1 Microsphere preparations containing neurokinin 1 receptor antagonist |
| 10/11/2001 | WO2001074390A2 The use of a calcium channel blocker for treating renal disorders |
| 10/11/2001 | WO2001074387A1 Use of aliphatic quaternary ammonium as adjuvant in a pharmaceutical composition administered by mucosal delivery |
| 10/11/2001 | WO2001074384A1 Combined interferon alfa and liposomal-encapsulated all-trans retinoic acid, including preparation and use |
| 10/11/2001 | WO2001074380A2 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 10/11/2001 | WO2001074370A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 10/11/2001 | WO2001074367A1 Pharmaceutical composition based on a non-steroid anti-inflammatory agent |
| 10/11/2001 | WO2001074363A1 Pharmaceutical composition containing 3-[4[2-phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy propanoicacid |
| 10/11/2001 | WO2001074358A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels |
| 10/11/2001 | WO2001074357A1 Hydrophilic molecular disperse solutions of carvedilol |
| 10/11/2001 | WO2001074356A1 Concentrated solutions of carvedilol |
| 10/11/2001 | WO2001074353A1 A synergistic anti-malarial formulation |
| 10/11/2001 | WO2001074350A1 Nasal administration of agents for the treatment of gastroparesis |
| 10/11/2001 | WO2001074347A2 Method for reducing adverse effects of a weight loss regimen |
| 10/11/2001 | WO2001074337A1 System for transporting active substances in a biological system |
| 10/11/2001 | WO2001074336A1 Method for producing a controlled-release preparation |
| 10/11/2001 | WO2001074335A1 Pharmaceutical kit comprising midodrine as an active drug substance |
| 10/11/2001 | WO2001074334A1 Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine |
| 10/11/2001 | WO2001074333A1 D and l etherlipid stereoisomers and liposomes |
| 10/11/2001 | WO2001074332A1 Pharmaceutical preparations and their manufacture |
| 10/11/2001 | WO2001074330A2 Method for treating dry eye |
| 10/11/2001 | WO2001074329A2 Sustained release beadlets containing stavudine |
| 10/11/2001 | WO2001074302A1 Proliposomal encapsulated preparations |
| 10/11/2001 | WO2001074279A1 Topical compositions containing prostaglandin e¿1? |
| 10/11/2001 | WO2001074165A1 Chitosan formulation with azelaic acid and other actives for the treatment of acne |
| 10/11/2001 | WO2001052833A8 Compositions for delivery of a cortisol antagonist |
| 10/11/2001 | WO2001036640A3 Human fgf-21 gene and gene expression products |
| 10/11/2001 | WO2001034677A8 Swelling and deswelling polymer blends |
| 10/11/2001 | WO2001028556A3 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use |
| 10/11/2001 | WO2001026621A3 Orally distintegrating composition comprising mirtazapine |
| 10/11/2001 | WO2001022956A3 NOVEL COMBINATION OF LOTEPREDNOL AND β2-ADRENOCEPTOR AGONISTS |
| 10/11/2001 | WO2001022947A3 Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same |
| 10/11/2001 | WO2001021153A3 Pharmaceutical gel containing active substances |
| 10/11/2001 | WO2001015777A8 Pulmonary-administration of mineral ascorbates |
| 10/11/2001 | WO2001012264A3 Topical azathioprine for the treatment of oral autoimmune diseases |
| 10/11/2001 | WO2001012154A3 Targeted lipid particles |
| 10/11/2001 | WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
| 10/11/2001 | WO2000050016A9 Compositions and methods for improving integrity of compromised body passageways and cavities |
| 10/11/2001 | WO2000042429A3 In vitro model for gastrointestinal inflammation |
| 10/11/2001 | US20010029399 Poly (vinyl alcohol) hydrogel |
| 10/11/2001 | US20010029357 Enhanced intra vaginal devices |
| 10/11/2001 | US20010029304 Cyclopentane heptan (ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 10/11/2001 | US20010029287 Thickener for cosmetic, drugs |
| 10/11/2001 | US20010029270 Aqueous solution |
| 10/11/2001 | US20010029269 Non-steroidal antiinflammatory agent |
| 10/11/2001 | US20010029264 In mixture with vitamin e, dimethylisosorbide, citric acid and polyoxyethylene glycol |
| 10/11/2001 | US20010029257 Transdermal adminitsering mixture of amine compound in carrier |
| 10/11/2001 | US20010029253 Composition for external application containing a beta-1,6-branched-beta-1,3-glucan |
| 10/11/2001 | US20010029249 Adenovirus comprising a gene coding for glutathione peroxidase |
| 10/11/2001 | US20010029248 Composition for and method of reducing low density lipoprotein cholesterol concentration |
| 10/11/2001 | US20010029046 A deepithelialized skin diffusion cell system comprising, donor and receptor compartments, and a deepithelized skin sample when placed its deepithelialized side faces into donar compartment and dermal side faces into receptor compartment |
| 10/11/2001 | US20010028896 Controlled release lipoic acid |
| 10/11/2001 | US20010028894 Composite structure having an adhesive matrix containing one or more active agents |
| 10/11/2001 | US20010028893 Pressurization |
| 10/11/2001 | US20010028889 Topical |
| 10/11/2001 | US20010027614 Spray drying apparatus and methods of use |
| 10/11/2001 | EP1145001A3 (in vitro) model for gastrointestinal inflammation |
| 10/11/2001 | DE10017102A1 Verfahren zur Herstellung von festen Kreatin-Dosierungsformen und dadurch erhältliche Dosierungsformen A process for producing solid creatine dosage forms and dosage forms obtainable thereby |
| 10/11/2001 | DE10015814A1 Arzneimittel zur Stimulierung der Leukopoese, zur Behandlung von Tumor- und Protozoenerkrankungen und Verfahren zu seiner Herstellung Medicines to stimulate leukopoiesis, for the treatment of tumors and protozoal diseases and process for its preparation |
| 10/11/2001 | DE10015783A1 Transdermales therapeutisches System zur Abgabe von Lerisetron Transdermal therapeutic system for the delivery of lerisetron |
| 10/11/2001 | DE10015479A1 Feste orale Darreichungsformen mit retardierter Wirkstofffreisetzung und hoher mechanischer Stabilität Solid oral dosage forms with delayed release and high mechanical stability |
| 10/11/2001 | DE10015468A1 Hartkapseln, enthaltend Polymerisate und Vinylestern und Polyethern, deren Verwendung und Herstellung Hard capsules containing polymers and vinyl esters and polyethers, their use and preparation |
| 10/11/2001 | DE10013942A1 Medicine preparation, comprises grinding animal or plant material in grinder whilst simultaneously adding liquid gas |
| 10/11/2001 | DE10011883A1 New non-solvated crystalline form of fluorinated estratriene-diol derivative, useful as antiestrogen e.g. for treating breast or endometrial cancer, chemotherapy-induced alopecia, endometriosis or anovulatory infertility |
| 10/11/2001 | CA2509546A1 A method of cleaning a contact lens |